Association of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection

Vaccine

Volumn 17, Issue 2, 1999, Pages 169-171

  Hopkins, Walter J ^a   Heisey, Dennis M ^a   Uehling, David T ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Human leucocyte antigen; Major histocompatibility complex; Mucosal immunity; Urinary tract infection

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR2 ANTIGEN; VACCINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HLA SYSTEM; HUMAN; IMMUNIZATION; INTRAVAGINAL DRUG ADMINISTRATION; MUCOSAL IMMUNITY; PHASE 2 CLINICAL TRIAL; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; URINARY TRACT INFECTION;

BACTERIAL INFECTIONS; BACTERIAL VACCINES; FEMALE; HLA ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGENETICS; PHENOTYPE; URINARY TRACT INFECTIONS; VAGINA;

EID: 0032889979     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00154-6     Document Type: Article

References (15)

1. Kunin C.M. Urinary tract infections in females. Clinical Infectious Diseases. 18:1994;1-12.
2. Uehling D.T., Hopkins W.J., Balish E. Vaginal mucosal immunization in recurrent UTIs. Primary Care Reviews. 2:1996;9-12.
3. Uehling D.T., Hopkins W.J., Balish E., Xing Y., Heisey D.M. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. Journal of Urology. 157:1997;2049-2052.
4. Janeway CW. Immunobiology: The immune system in health and disease, 2nd ed. Garland, New York, 1997.
5. Brett S.J., Blau J., Hughes-Jenkins C.M., Rhodes J., Liew F.Y., Tite J.P. Human T cell recognition of influenza A nucleoprotein. Specificity and genetic restriction of immunodominant T helper cell epitopes. Journal of Immunology. 147:1991;984-991.
6. Walker M., Szmuness W., Stevens C.E. Genetics of anti-HBs responsiveness: HLA-DR7 and non-responsiveness to hepatitis B vaccination. Transfusion. 21:1981;601.
7. Raz R., Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New England Journal of Medicine. 329:1993;753-756.
8. Terasaki P., McClelland J.P. Microdroplet assay of human serum cytotoxins. Nature. 204:1964;998.
9. Singal DP, Naipaul N, Hidalgo R. Microdroplet B-lymphocyte cytotoxicity test. NIAID Manual of Tissue Typing Techniques 1976, DHEW Publication No. (NIH) 76-545.
10. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological typing in clinical practice including donor-specific matching in cadaveric transplantation. Tissue Antigens. 39:1992;225-235.
11. SAS Institute I: SAS/STAT Users Guide, Version 6. SAS Institute, Cary, North Carolina, 1989.
12. Hopkins WJ, Heisey DM, Lorentzen DF, Uehling DT. A comparative study of major histocompatibility complex and red blood cell antigen phenotypes as risk factors for recurrent urinary tract infections. Journal of Infectious Diseases, 1998;177:1296-1301.
13. McDermott A.B., Zuckerman J.N., Sabin C.A., Marsh S.G.E., Madrigal J.A. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens. 50:1997;8-14.
14. Bahr G.M., Rook G.A., Shahin A., Stanford J.L., Sattar M.I., Behbehani K. HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis. Clinical and Experimental Immunology. 72:1988;26-31.
15. Repo H., Leirisalo-Repo M., Gripenberg M., Koskimies S., Kontiainen S., Laitinen O. Yersinia arthritis, immune functions, and histocompatibility antigens. Acta Pathologica Micobiologica Immunologica et Scandinavica. 94:1986;245-252.